DESIGN AND PREPARATION OF PULSATILE RELEASE TABLET AS A NEW ORAL-DRUG DELIVERY SYSTEM

被引:38
作者
ISHINO, R
YOSHINO, H
HIRAKAWA, Y
NODA, K
机构
[1] Pharmaceutics Research Laboratory, Tanabe Seiyaku Co., Ltd, Osaka 532, 16-89, Kashima 3-chome, Yodogawa-ku
关键词
PULSATILE DRUG RELEASE; DRY-COATED TABLET; SWELLABLE DISINTEGRANT; WATER PENETRATION RATE; ISONIAZID; HYDROGENATED CASTOR OIL; POLYETHYLENEGLYCOL; 6000; TIME-CONTROLLED DISINTEGRATION;
D O I
10.1248/cpb.40.3036
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To achieve time-controlled or site specific delivery of a drug in the gastrointestinal tract, an orally applicable pulsatile drug release system with the dry-coated tablet form was developed. The system consisted of a less water permeable outer shell and a swellable core tablet; from such a system, the drug was expected to be rapidly released after a certain period of time on the basis of the time-controlled disintegration mechanism. Various model disks of outer shell, consisting of hydrogenated castor oil and polyethyleneglycol 6000, were tested for their water penetration rate. The experimental results showed that water penetration proceeded obeying the boundary retreating mechanism, so that the lag time of the system could be controlled by changing either the thickness or the composition of the outer shell. The swelling force of various commercially available disintegrants was quantitatively compared, and it was found that carboxymethylcellulose calcium was the preferable disintegrant to be used for the core tablet. On the basis of the results of a series of fundamental studies, various pulsatile release tablets of isoniazid with different lag times were designed. In the in vitro dissolution test, typical pulsatile release was achieved for all the tablets prepared, and a good correlation was found between the observed lag time and the estimated lag time calculated from an empirical equation deduced from the thickness and polyethyleneglycol 6000 content of the outer shell.
引用
收藏
页码:3036 / 3041
页数:6
相关论文
共 14 条
[1]  
BOGENTOFT C, 1983, ACTA PHARM SUEC, V20, P311
[2]   THE USE OF AN ELASTIC RECOVERY INDEX AS A CRITERION OF COMPACTIONAL BEHAVIOR OF SOME DIRECT COMPRESSION BASES [J].
CELIK, M ;
TRAVERS, DN .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (2-3) :299-314
[3]   A NEW IBUPROFEN PULSED RELEASE ORAL DOSAGE FORM [J].
CONTE, U ;
COLOMBO, P ;
LAMANNA, A ;
GAZZANIGA, A ;
SANGALLI, ME ;
GIUNCHEDI, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (14-16) :2583-2596
[4]   ENDOCRINE REPRODUCTIVE PULSATILE DELIVERY SYSTEMS [J].
CREASY, GW ;
JAFFE, ME .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 6 (01) :51-56
[5]   AN ORAL PREPARATION TO RELEASE DRUGS IN THE HUMAN-COLON [J].
DEW, MJ ;
HUGHES, PJ ;
LEE, MG ;
EVANS, BK ;
RHODES, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :405-408
[6]   NITRATE TOLERANCE - A REVIEW OF THE EVIDENCE [J].
FLAHERTY, JT .
DRUGS, 1989, 37 (04) :523-550
[7]  
HATA T, 1989, PHARM TECH JAPAN, V4, P1415
[8]   INFLUENCE OF INTERNAL STRUCTURE ON KINETICS OF DRUG RELEASE FROM WAX MATRIX TABLETS [J].
ISHINO, R ;
YOSHINO, H ;
HIRAKAWA, Y ;
NODA, K .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (12) :3440-3445
[9]  
ISHINO R, 1991, CHEM PHARM BULL, V39, P3318
[10]  
ITO A, 1991, JPN J HOSP PHARM, V17, P204